ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Wow of the week: Scientists use layered clay to grow bone cells

Featured Story

Wow of the week: Scientists use layered clay to grow bone cells

May 18, 2013 8:15 am by | 0 Comments

It was a big news for stem cells this week, particularly from a group of researchers who successfully transformed human skin cells into embryonic stem cells, showing that it’s possible to clone embryonic stem cells that are genetically identical to the person from whom they’re sourced. But another interesting stem ... Read more
Lundbeck: Trial shows Vortioxetine is safe and eases depression symptoms

Lundbeck: Trial shows Vortioxetine is safe and eases depression symptoms

May 18, 2013 2:05 pm by | 0 Comments

COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck and Japanese partner Takeda said on Saturday that data from clinical phase III studies with the antidepressant vortioxetine had shown significant improvement in ... Read more
Sanofi plans regulatory filings for myelofibrosis drug treatment after successful drug trial

Sanofi plans regulatory filings for myelofibrosis drug treatment after successful drug trial

May 18, 2013 10:00 am by | 0 Comments

PARIS (Reuters) - French drugmaker Sanofi said a late-stage Phase III trial of a drug designed to treat myelofibrosis led to positive results.Myelofibrosis is a rare, life-threatening condition that involves ... Read more
Biotech, meet service provider. This startup strives to streamline the process of outsourcing

Biotech, meet service provider. This startup strives to streamline the process of outsourcing

May 17, 2013 11:26 am by | 0 Comments

The “virtual” business models that have become common in many biotech startups may allow companies to operate with less capital, but they also present their own set of challenges.One of ... Read more
First phase III trial of Novo Nordisk’s hemophilia drug complete

First phase III trial of Novo Nordisk’s hemophilia drug complete

May 17, 2013 8:43 am by | 0 Comments

COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia drug, N9-GP.Novo Nordisk said in ... Read more
Bayer acne drug deemed safe treatment for some women

Bayer acne drug deemed safe treatment for some women

May 17, 2013 8:26 am by | 0 Comments

LONDON (Reuters) - Bayer's acne pill Diane 35 and its generic versions are safe to use in certain women when other options have failed, the European Medicines Agency said on ... Read more
Sanofi agrees to reorganize Toulouse research site, not close it

Sanofi agrees to reorganize Toulouse research site, not close it

May 17, 2013 8:19 am by | 0 Comments

PARIS (Reuters) - Sanofi said it would overhaul rather than exit its Toulouse research site, as it seeks to break an impasse with the French government which opposed the drugmaker's ... Read more
Key stakeholder Teva tries to stay out of limelight in drug controversy

Key stakeholder Teva tries to stay out of limelight in drug controversy

May 17, 2013 5:14 am by | 0 Comments

The recent controversy surrounding the morning-after contraceptive pill called Plan B One-Step has been argued in political, regulatory, and legal circles. But Teva Pharmaceuticals Ltd., which makes the drug and ... Read more
The numbers game and the new edition of the psychiatrists’ manual

The numbers game and the new edition of the psychiatrists’ manual

May 17, 2013 12:05 am by | 0 Comments

NEW YORK (Reuters) - The long-awaited, controversial new edition of the bible of psychiatry can be characterized by many numbers: its 947 pages, its $199 price tag, its more than ... Read more
Adding plant-derived steroids to red yeast rice doesn’t help lower LDL levels

Adding plant-derived steroids to red yeast rice doesn’t help lower LDL levels

May 16, 2013 1:44 pm by | 0 Comments

NEW YORK (Reuters Health) - Adding a plant-derived compound called a sterol to the cholesterol-lowering agent red yeast rice doesn't make it work any better, according to a new study."I ... Read more
Source reveals Sweden’s Recipharm is seeking advice on a partial sale or listing

Source reveals Sweden’s Recipharm is seeking advice on a partial sale or listing

May 16, 2013 12:00 pm by | 0 Comments

STOCKHOLM (Reuters) - Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing on the Stockholm exchange, a source close to ... Read more
With a band of biotech collaborators, RuiYi sets sail developing new biologic drugs for China

With a band of biotech collaborators, RuiYi sets sail developing new biologic drugs for China

May 16, 2013 9:37 am by | 0 Comments

The La Jolla, California, biotech formerly known as Anaphore is looking a little different these days. Under the leadership of former Fate Therapeutics CEO Paul Grayson, Anaphore changed its name ... Read more
FDA warning didn’t decrease use of drug in for-profit dialysis centers

FDA warning didn’t decrease use of drug in for-profit dialysis centers

May 16, 2013 9:07 am by | 0 Comments

NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers still gave their kidney failure patients more of a certain anemia drug than ... Read more
Despite early reports Novartis has no plans to buy Actavis

Despite early reports Novartis has no plans to buy Actavis

May 16, 2013 8:57 am by | 0 Comments

ZURICH (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on ... Read more
Bayer will buy German herbal medicine maker Steigerwald

Bayer will buy German herbal medicine maker Steigerwald

May 16, 2013 7:44 am by | 0 Comments

FRANKFURT (Reuters) - Germany's largest drugmaker Bayer said it agreed to buy privately held Steigerwald Arzneimittelwerk GmbH, a maker of herbal treatments.Bayer said on Thursday that Steigerwald, based in Darmstadt, ... Read more
AstraZeneca needs new new products as others lose patent protection, accelerates drug pipeline

AstraZeneca needs new new products as others lose patent protection, accelerates drug pipeline

May 16, 2013 6:10 am by | 0 Comments

LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers ... Read more